Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis.

about

Oxidative stress in the pathology and treatment of systemic lupus erythematosus Oscillating high glucose enhances oxidative stress and apoptosis in human coronary artery endothelial cells.Oxidative stress is associated with migraine and migraine-related metabolic risk in females.

P2860

Q33715508-0A806CC4-8B1D-4C7E-A825-69863EB7300A Q38991668-429C1380-5A71-4DC7-8DCE-11E2427B99AF Q51471653-637A6CE0-4BF8-40F3-9213-A19D063EE7E4

P2860

Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis.

Item

http://www.wikidata.org/entity/Q43080307

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis.

@en

Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis.

@nl

type

Item

label

Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis.

@en

Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis.

@nl

prefLabel

Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis.

@en

Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis.

@nl

P1476

Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis.

@en

P2093

Alla Tikhaze

http://www.w3.org/2001/XMLSchema#string

Elena Kumskova

http://www.w3.org/2001/XMLSchema#string

Galina Konovalova

http://www.w3.org/2001/XMLSchema#string

Galina Zemtsovskaya

http://www.w3.org/2001/XMLSchema#string

Jelena Abina

http://www.w3.org/2001/XMLSchema#string

Margus Viigimaa

http://www.w3.org/2001/XMLSchema#string

Vadim Lankin

http://www.w3.org/2001/XMLSchema#string

P2860

Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?

Oxidative stress in patients with primary pulmonary hypertension.

Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study).

Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.

Interrelation between compensation of carbohydrate metabolism and severity of manifestations of oxidative stress in type II diabetes mellitus.

Oxidized low-density lipoprotein cholesterol is associated with decreases in cardiac function independent of vascular alterations.

Oxidative stress in atherosclerosis and diabetes.

Oxidative stress in patients with chronic heart failure and type 2 diabetes mellitus.

Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.

Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients.

P304

164-168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08037051.2010.484158

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20429692

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

biomarker

Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis.

about

P2860

P2860

Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921